Skip to main content

Clinical outcomes associated with long-term exposure to airborne particulate pollution in kidney transplant recipients



Researchers have yet to investigate the specific association between 10-μm particulate matter (PM10) levels and the risk of graft failure, kidney disease, or the functional decline of transplanted kidneys, in kidney transplant recipients (KTRs). Furthermore, we know very little about the association between PM10 levels and the development of allograft rejection in transplanted kidneys. Identification of air pollution as a potential contributor to kidney disease could help reduce future disease burden, stimulate policy discussions on the importance of reducing air pollution with respect to health and disease, and increase public awareness of the hazards of air pollution. We aimed to evaluate the relationship of PM10 with the risk of graft failure, mortality, and decline of graft function in KTRs.


Air pollutant data were obtained from the Korean National Institute of Environmental Research. We then investigated potential associations between these data and the clinical outcomes of 1532 KTRs who underwent kidney transplantation in a tertiary hospital between 2001 and 2015. Survival models were used to evaluate the association between PM10 concentrations and the risk of death-censored graft failure (DCGF), all-cause mortality, and biopsy-proven rejection (BPR), over a median follow-up period of 6.31 years.


The annual mean PM10 exposure after kidney transplantation was 27.1 ± 8.0 μg/m3. Based on 1-year baseline exposure, 1 μg/m3 increase in PM10 concentration was associated with an increased risk of DCGF (hazard ratio (HR): 1.049; 95% confidence interval (CI): 1.014–1.084) and BPR (HR: 1.053; 95% CI: 1.042–1.063). Fully adjusted models showed that all-cause mortality was significantly associated with 1-year average PM10 concentrations (HR, 1.09; 95% CI, 1.043 to 1.140).


Long-term PM10 exposure is significantly associated with BPR, DCGF, and all-cause mortality in KTRs.

Peer Review reports


Exposure to outdoor air pollution is a leading cause of global disease burden and accounts for over four million deaths each year [1]. Increased concentrations of daily fine particulates that are 10 μm in aerodynamic diameter (PM10) are associated with an increased risk of cardiovascular disease [2, 3], stroke [4], heart failure [5, 6], death [7], and reduced life expectancy, as well as a host of other adverse health outcomes [1].

In a large cohort of veterans in the United States [8, 9], higher amounts of fine particulate matter were associated with an increased risk of incident chronic kidney disease (CKD), a reduction in estimated glomerular filtration rate (eGFR), and end-stage renal disease (ESRD). Experimental laboratory evidence also indicates that long-term exposure to micro-particles leads to disturbances in renal hemodynamics, thus promoting oxidative stress and systemic inflammation in the renal tissue; these factors exacerbates acute kidney injury and further promotes chronic renal injury in murine models [10, 11].

Previous studies have focused only on evaluating the association between PM10 and the outcomes of kidney diseases in native kidneys. However, researchers have yet to investigate the specific association between PM10 levels and the risk of graft failure, kidney disease, or the functional decline of transplanted kidneys, in kidney transplant recipients (KTRs). Furthermore, we know very little about the association between PM10 levels and the development of allograft rejection in transplanted kidneys. The identification of air pollution as a potential contributor to kidney disease could help reduce future disease burden, stimulate policy discussions on the importance of reducing air pollution with respect to health and disease, and increase public awareness relating to the hazardous nature of air pollution.

In the present study, we developed a longitudinal national cohort of KTRs and investigated the relationship between PM10 levels and the risk of biopsy-proven rejections (BPR), death-censored graft failure (DCGF), and mortality.


Study population

This was a retrospective cohort study involving data generated between January 2001 and December 2015 at the Seoul National University Hospital and Seoul National University Boramae Medical Center. Initially, a total of 1531 adult participants (> 18 years) were included. However, a number of patients were then excluded for the following reasons: (1) multiple organ transplantation (n = 61) and double kidney transplantation (n = 85); (2) graft failure within 3 months of transplantation (n = 7), and (3) mortality within 3 months of transplantation (n = 16). Only the participants whose data included a zip code were included in the final analysis.

We also collected a range of baseline information, including recipient/donor age, gender, the relationship between donor and recipient, smoking status, body mass index (BMI), the incidence of diabetes and hypertension, chronic glomerulonephritis as a cause of ESRD, the duration of renal replacement therapy (RRT) prior to transplantation, and the type of previous RRT. We also collated data relating to a range of immunological factors, including preemptive transplantation (defined by the absence of dialysis prior to transplantation), donor status (living or deceased), ABO incompatibility, and a number of HLA-A, −B, and -DR mismatches.

Air pollution data

Across the South Korea, there are eleven different types of monitoring sites operated by the Ministry of Environment and local governments. These monitoring sites are situated across 584 locations in 114 cities and counties. This study used data arising from 373 monitoring stations situated in both urban and roadside positions.

PM10 concentration data for 2001 and 2015 were provided by the Korean National Institute of Environmental Research ( We collated hourly PM10 data from each of our 373 national monitoring sites. In addition, we used daily mean PM10 concentrations for individual study populations according to the respective district of each enrolled patient, as determined by the residential address stated on medical records.

In this study, we were interested in the effects of long-term exposure. To examine the effect of the amount of exposure at the time of outcome, rather than at the time of kidney transplantation, the exposure concentration was varied from 1 to 5 years before the clinical outcomes. We analyzed the effects of exposure by applying the average concentration values for each of these periods.

Laboratory measurements and study outcomes

Graft function was assessed by determining serum creatinine levels after transplantation. The eGFR was calculated using the MDRD GFR equation [12]. Graft failure was defined as an irreversible loss of graft function with the need to restart dialysis or to undergo re-transplantation. DCGF data were also analyzed. Surveillance biopsies were routinely performed 1–2 weeks after transplantation in almost all patients. Additional biopsies were performed when renal graft function was impaired, or when there was a considerable reduction in urine output. Rejection was determined according to the diagnostic criteria proposed at the 2007 Banff Conference [13], while BPRs involved acute T-cell mediated rejection (TCMR) and acute antibody-mediated rejection (ABMR), and chronic rejections.

Statistical analysis

Demographic and clinical characteristics of the overall cohort are presented as frequencies (percentages) for categorical variables and as means (with standard deviation, SD) for continuous variables.

To investigate the association between the clinical outcomes of transplantation patients and PM10 concentration, we calculated Kaplan-Meier estimates of survivor functions and compared survival curves between groups of patients according to a pre-determined cut-off value, which was defined as the median annual mean PM10 concentration.

Next, the median PM10 concentration was used to divide PM10 data into two groups, and a log rank test was used to test the null hypothesis. We then used the Cox proportional hazards survival model to investigate the association between the 1-year mean PM10 concentrations (for the 5-year study period) before the events occurred, along with the individual and clinical outcomes. Finally, we adjusted our data to take account of covariates. As the definition of exposure was dependent on the annual mean obtained from an air monitoring station in each district, we also collated data from the year prior to the event. Additionally, subgroup analysis was performed for two groups of TCMR and ABMR according to the mechanism of occurrence of the biopsy-proven rejection event, one of the outcomes.

To explore whether this association was non-linear or linear, we considered a non-linear relationship via smoothing splines. Splines are mathematical constructs made of fragments of polynomial functions that are stitched together to form a smooth curve. In order to identify a smoothing spline, we used the penalized partial likelihood method; this is known to be an effective method for survival analysis.

We used models that incorporated subject-specific random effects to account for unmeasured subject characteristics that influenced the hazard of the occurrence of the outcome. In our research, these models were then extended to models that incorporated cluster-specific random effects to account for within-cluster homogeneity in outcomes. Moreover, we investigated whether different concentrations of PM10 affected the health of kidney transplant patients using the two-pollutant model of PM10 with adjustment for SO2, CO, NO2, and O3 and whether these effects differed by regions. All statistical analyses were performed using R (3.6.0) and SAS version 9.4.


Initially, we recruited a total of 1532 individuals. However, we then excluded 240 patients aged < 19 years, 61 patients who underwent multiple organ transplantation, and 85 patients who underwent kidney transplantation more than twice. Consequently, our final analysis featured 1146 eligible KTRs (Fig. 1). The demographic characteristics of the final study participants are presented in Table 1. The mean age of the recipients at the time of kidney transplantation was 45.0 ± 12.5 years and that of the donors was 42.6 ± 13.0 years. The majority of the study population were males (60.12%), and 11.61% were smokers. Overall, 91.97% of our patients were hypertensive and 34.12% had diabetes mellitus. When measured 6 months after transplantation, the eGFR was 56.0 ± 17.5 ml/min/1.73 m2. The incidence of preemptive kidney transplantation was 29.8%, while that of ABO incompatible kidney transplantation was 5.9%. The geographic locations of the participants are shown in Figure S1. Figure 2 shows the annual mean PM10 concentrations for each year during the entire study period. The overall mean PM10 concentration was 52.68 ± 30.49 μg/m3. The mean PM10 exposure showed a slight increase compared to the overall mean PM10 concentration between 2001 and 2009 (yearly mean PM10 exposure was 60.22, 59.19, 58.05, 58.85, 57.83, 55.9, 56.8, 54.22, and 53.1 μg/m3, respectively), but then a slight decrease from 2010 to 2015 (yearly mean PM10 exposure was 51.11, 49.84, 44.96, 48.89, 48.94, and 47.63 μg/m3, respectively).

Fig. 1

Flow diagram showing patient enrollment and application of exclusion criteria

Table 1 Demographic and baseline characteristics of the overall study population
Fig. 2

Distribution of baseline PM10 exposure by year. Boxes display the 25-75th percentiles (interquartile range: IQR); the center line represents the median concentration. Whiskers indicate the most extreme data within 3 IQRs of the box, while circles indicate outlying values

Mean follow-up time was 6.3 ± 4.2 years and a total of 51 deaths (4.5%), 78 cases of DCGF (6.8%), and 549 cases of BPR (47.9%) were recorded. The Kaplan-Meier survival curves for BPR, DCGF, and mortality were significantly worse in the group exposed to higher concentrations of PM10 than in the group exposed to lower concentrations (Fig. 3).

Fig. 3

Survival curves by median value of the annual mean PM10 concentration. (a) Biopsy-proved rejection (BPR), (b) Death-censored graft failure (DCGF), and (c) All-cause mortality. Note: The units for the X-axis “Time” of the Kaplan meier curve are months

Overall, our data indicated that a 1 μg/m3 increase in PM10 concentration was associated with an increased risk of BPR (hazard ratio [HR]: 1.053; 95% confidence interval [CI]: 1.042–1.063), graft failure (HR: 1.049; 95% CI: 1.014–1.084), and mortality (HR: 1.090; 95% CI: 1.043–1.140) in our analyses considering exposure over a 1-year period with regards to prospective clinical outcome (Table 2). In addition, we performed analyses of various PM10 exposure values, from 2-year to 5-years (S1-S3 Tables). According to the results of this sensitivity analysis, the effect of PM10 on the clinical outcome of kidney transplant patients consistently showed a significant effect according to the concentration value of PM10 over various periods. Spline analyses suggested a linear relationship between PM10 concentration and the risk of BPR (P-value for nonlinearity < 0.031), DCGF (P-value for nonlinearity = 0.2), and all-cause mortality (P-value for nonlinearity = 0.7; Fig. 4). The slope of the mortality plot showed a linear trend. For BPR, we observed a significant increasing trend in nonlinearity with a slight flat turn after the 1-year moving average PM10 concentration of 70 μg/m3. However, only a limited amount of data was acquired at these higher concentrations, as reflected by the wide CI; this confirms our observation that a departure from linearity cannot be established.

Table 2 Risk of outcomes in PM 10 concentration for average of 1 year from events day
Fig. 4

The risk of renal outcomes according to PM10 concentrations. Models were adjusted for age, sex, diabetes mellitus, hypertension, eGFR 6 months after surgery, BMI, HLA Ag Mismatch, the cause of ESRD, albumin, phosphorus, preemptive kidney transplantation, donor age, donor sex, and donor type (deceased). a Risk of incident biopsy-proven rejections (BPR) (P for nonlinearity = 0.000032). b Risk of incident death-censored graft failure (DCGF) (P for nonlinearity = 0.07). c Risk of all–cause mortality (P for nonlinearity = 0.4)

The results for the gamma frailty model is reported in Table 3. The estimate of the within-cluster correlation of outcomes and the variance of the frailty distribution for clinical outcomes of BPR, DCGF, and all-cause mortality was 0.05304, 0.0001, and 0.03079, respectively. Thus, the within-cluster correlation of survival times was marginally greater than 0.007, 0.012, and 0.186. After adjustment for air pollutants, the associations between PM10 and BPR and between DCGF and all-cause mortality were significant for all outcomes. The estimates of the hazard ratio for BPR with one unit increase in PM10 concentration decreased significantly after adjustment for SO2 (0.2%), CO (0.4%), NO2 (4.1%), and O3 (0.4%). Notably, the hazard ratio for GF with the same increase in PM10 concentration increased by 6.2%, and the hazard ratio for mortality increased by 6.8% after adjustment for O3 (Table 4). As a result of subgroup analysis of two groups according to the BPR mechanism, the hazard ratio of PM10 was 1.053 (95% CI: 1.043–2.895) in the TCMR group, and the HR in the ABMR group was 1.133 (95%CI:1.054–1.219), which were statistically significant (Table 5).

Table 3 Risk of outcomes of 1-year average PM10 concentrations based on a random-effects model
Table 4 Hazard Ratio in association with annual average concentration of PM10 after adjusting for co-pollutants
Table 5 The results of subgroup analysis by types of BPR


To the best of our knowledge, this is the first study to examine the association between long-term exposure to PM10 and clinical outcomes in KTRs. In this study, we demonstrated that long-term exposure to higher 1-year moving mean PM10 concentration significantly increased the risk of all-cause mortality, DCGF, and BPR in KTRs. We used the observations of the monitoring stations at the local level and applied the average values over several periods to conduct a sensitivity analysis. In addition, by considering the unmeasured confounder, the characteristic of regions, we used models with a random effect term. When considering the within-cluster correlation of survival times, random effects were significant only in DCGF and BPR and not mortality. The results of both models, the model with random effects or not, showed that PM10 had a statistically significant effect on the health of kidney transplant patients.

Several epidemiological studies have reported the association between particulate matter and CKD. For example, a weak acceleration in the progression of albuminuria was observed during chronic exposure to PM10 in the Multi-Ethnic Study of Atherosclerosis cohort. In China, long-term exposure to PM2.5 was associated with an increased risk of membranous nephropathy in 71,151 native kidney biopsy samples [14]. Another longitudinal observational cohort study of US veterans reported the association between PM2.5 concentration and a higher risk of CKD incidence and progression to ESRD [8]. Among 21,656 Taiwanese adults [15], individual exposure to PM10, coarse particles, or PM2.5 was related to reduced renal function. In a nationwide cohort study [9], Bowe et al. showed that higher concentrations of PM10, NO2, and CO, were associated with increased risks of CKD, renal function decline, and ESRD. In a recent cohort study in the US observed that higher annual PM2.5 exposure was associated the increased albuminuria and a higher risk of CKD [16].

In the present study, we found that elevated levels of PM10 were consistently associated with a significantly higher risk of adverse renal transplantation outcomes, including DCGF, BPR, and all-cause mortality. Our sensitivity analyses indicated that our results were robust, including the examination of various exposure durations and analyses involving fully adjusted models. We found that PM10 affects each outcome even after adjusting for other air pollutants. In addition, the effects of CO and O3, which are other air pollutants that were adjusted, were statistically significant.

Table 3 shows the covariance estimates and associated statistics for fixed effects and the variance of frailty. As shown in the table, the frailty value is significantly greater than zero (θ = 0.05; p value = 0.0078). Furthermore, our result shows that there are factors that influnence the hazard of BPR. It is obvious from our results, that the districts were important (p value = 0.0078) and gamma frailty with a covariance estimates of 0.05 shows that there were unmeasured districts effects present in the model.

The underlying biological mechanisms that may explain the novel association between long-term PM10 exposure and renal outcomes in KTRs is unclear. Classically, the inhalation of particulate matters activates pulmonary inflammatory cells that may trigger a systemic inflammatory response that triggers a cascade of events, ultimately affecting the body’s cardiovascular system [17]. Recent studies have reported that the inhaled nanoparticles rapidly translocate from the pulmonary tissues into the vascular systemic circulation and subsequently accumulate in various organs, such as the heart, liver, and kidneys; these observations have been made in studies involving both animals and humans [18,19,20,21]. These particles have the capacity to induce pulmonary inflammation and oxidative stress; parallel pathways can also be activated in the systemic circulation and organ systems. Research has also shown that inflammatory markers, including C-reactive protein, fibrinogen, white blood cell counts, and IL-6, are positively associated with PM exposure [22, 23], and that short-term changes in PM concentrations cause alterations in these key inflammatory biomarkers [24, 25].

Other studies have investigated kidney damage following sub-chronic exposure to PM2.5 by analyzing the levels of early kidney biomarkers, histological changes, induction of the angiotensin and bradykinin system, and by measuring changes in blood pressure [26, 27]. In a previous study, involving an animal model, long-term exposure to PM2.5 was associated with kidney damage, including inflammatory cell infiltration, tubulo-interstitial fibrosis, and mesangial expansion; collectively, these effects caused an impairment in renal function [28].

Our data showed that prolonged long-term exposure to PM10 was associated with higher risks of transplant kidney rejections in KTRs. However, there is little in the current literature to explain the relationship between PM10 exposure and the risk of graft rejections. However, there is some evidence originating from studies involving the recipients of other transplanted organs, such as lung transplant recipients that suggests that PM may trigger rejection of the transplanted organ. Recent studies have reported that exposure to traffic-related air pollution independently increased the risk of bronchiolitis obliterans syndrome, a condition that is clinically correlated with chronic rejection in lung transplant patients [29], and also associated with the development of chronic lung allograft dysfunction, a condition that is related to both acute and chronic allograft rejections [30, 31]. Acute rejection presents a major problem after organ transplantation, and is a recognized risk factor for chronic rejection and all-cause mortality. The authors of these previous papers provided evidence for the increased risk of rejection after lung transplantation with temporal changes in particulate air pollution, and reported this was associated with bronchoalveolar lavage neutrophilia and lymphocytosis. This tissue damage was explained by the novel effect of PM on Th17 polarization via the aryl hydrocarbon receptor [32]. However, the precise biological mechanisms by which exposure to PM10 can trigger kidney rejection is not yet fully understood. One explanation is that the inhaled PM may directly or indirectly induce oxidative stress and inflammation in the transplanted kidney and that this induces endothelial cell dysfunction and exacerbates the production of reactive oxygen species. These complicated processes may be responsible for shifting the immune responses to an effector phenotype, thus leading to the loss of self-tolerance and a shift towards allograft rejection. Further preclinical and epidemiological studies are now required to investigate the association between air pollution and allograft rejection, especially in KTRs.

One particular strength of our study is that we investigated a large contemporary Korean cohort of KTRs with a long-term follow-up of 15 years. Because we had access to comprehensive long-term air pollutant data, we were able to adjust the data for multiple donors and recipient variables. Moreover, this study used BPR data as the chief outcome to evaluate the impact of PM10. However, this study also has several limitations that need to be considered. First, the study participants were mostly South Koreans; therefore, the findings may not be generalizable to other populations. Although we accounted for known confounding factors, and region with frailty survival analysis, we cannot ignore the possibility and potential effects of unknown or non-measured confounders. Therefore, if the sample size of the study was large, and subjects were evenly distributed in the sub-regional unit, it can be carefully assumed that the effect of size on the region may increase.


In summary, we demonstrate a significant association between PM10 concentrations and the risk of graft failure development, all-cause mortality, and BPR in KTRs. Continued efforts to improve air quality may help to reduce the burden of renal outcome in KTRs.

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.



10-μm particulate matter


Kidney transplant recipients


Death-censored graft failure


Acute T-cell mediated rejection


Acute antibody-mediated rejection


Biopsy-proven rejection


Chronic kidney disease


Estimated glomerular filtration rate


Body mass index


Renal replacement therapy


Standard deviation


Hazard ratio


Confidence interval


  1. 1.

    Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Balakrishnan K, Brunekreef B, Dandona L, Dandona R: Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907–18.

  2. 2.

    Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356(5):447–58.

  3. 3.

    Brook RD, Newby DE, Rajagopalan S. Air pollution and cardiometabolic disease: an update and call for clinical trials. Am J Hypertens. 2018;31(1):1–10.

  4. 4.

    Shah AS, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, Langrish JP, Newby DE, Mills NL. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ. 2015. p. 350.

  5. 5.

    Shah AS, Langrish JP, Nair H, McAllister DA, Hunter AL, Donaldson K, Newby DE, Mills NL. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013;382(9897):1039–48.

  6. 6.

    Downward GS, van Nunen EJ, Kerckhoffs J, Vineis P, Brunekreef B, Boer JM, Messier KP, Roy A, Verschuren WMM, van der Schouw YT. Long-term exposure to ultrafine particles and incidence of cardiovascular and cerebrovascular disease in a prospective study of a Dutch cohort. Environ Health Perspect. 2018;126(12):127007.

  7. 7.

    Rajagopalan S, Al-Kindi SG, Brook RD. Air pollution and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(17):2054–70.

  8. 8.

    Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Particulate matter air pollution and the risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2018;29(1):218–30.

  9. 9.

    Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: a cohort study. The Lancet Planetary Health. 2017;1(7):e267–76.

  10. 10.

    Nemmar A, Al-Salam S, Zia S, Yasin J, Al Husseni I, Ali BH. Diesel exhaust particles in the lung aggravate experimental acute renal failure. Toxicol Sci. 2010;113(1):267–77.

  11. 11.

    Nemmar A, Karaca T, Beegam S, Yuvaraju P, Yasin J, Hamadi NK, Ali BH. Prolonged pulmonary exposure to diesel exhaust particles exacerbates renal oxidative stress, inflammation and DNA damage in mice with adenine-induced chronic renal failure. Cell Physiol Biochem. 2016;38(5):1703–13.

  12. 12.

    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461–70.

  13. 13.

    Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell B, Halloran P, Colvin R, Akalin E. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials. In. Wiley Online Library; 2018.

  14. 14.

    Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. Clin J Am Soc Nephrol. 2016;27(12):3739–46.

  15. 15.

    Yang Y-R, Chen Y-M, Chen S-Y, Chan C-C. Associations between long-term particulate matter exposure and adult renal function in the Taipei metropolis. Environ Health Perspect. 2017;125(4):602–7.

  16. 16.

    Blum MF, Surapaneni A, Stewart JD, Liao D, Yanosky JD, Whitsel EA, Power MC, Grams ME. Particulate matter and albuminuria, glomerular filtration rate, and incident CKD. Clin J Am Soc Nephrol. 2020;15(3):311–9.

  17. 17.

    Seaton A, Godden D, MacNee W, Donaldson K. Particulate air pollution and acute health effects. Lancet. 1995;345(8943):176–8.

  18. 18.

    Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, Wilson S, Vesey AT, Fokkens PH, Boere AJF. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano. 2017;11(5):4542–52.

  19. 19.

    Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health, Part A. 2002;65(20):1531–43.

  20. 20.

    Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010;28(12):1300–03.

  21. 21.

    Kreyling W, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health, Part A. 2002;65(20):1513–30.

  22. 22.

    Rückerl R, Phipps RP, Schneider A, Frampton M, Cyrys J, Oberdörster G, Wichmann HE, Peters A. Ultrafine particles and platelet activation in patients with coronary heart disease–results from a prospective panel study. Part Fibre Toxicol. 2007;4(1):1–14.

  23. 23.

    Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int J Epidemiol. 2006;35(5):1347–54.

  24. 24.

    Delfino RJ, Staimer N, Tjoa T, Gillen DL, Polidori A, Arhami M, Kleinman MT, Vaziri ND, Longhurst J, Sioutas C. Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspect. 2009;117(8):1232–8.

  25. 25.

    Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect. 2008;116(7):898–906.

  26. 26.

    Aztatzi-Aguilar O, Uribe-Ramírez M, Narváez-Morales J, De Vizcaya-Ruiz A, Barbier O. Early kidney damage induced by subchronic exposure to PM 2.5 in rats. Particle and fibre toxicology. 2016;13(1):1–20.

  27. 27.

    Honda T, Hirakawa Y, Nangaku M. The role of oxidative stress and hypoxia in renal disease. Kidney Res Clin Pract. 2019;38(4):414.

  28. 28.

    Busso IT, Mateos AC, Juncos LI, Canals N, Carreras HA. Kidney damage induced by sub-chronic fine particulate matter exposure. Environ Int. 2018;121:635–42.

  29. 29.

    Nawrot TS, Vos R, Jacobs L, Verleden SE, Wauters S, Mertens V, Dooms C, Hoet PH, Van Raemdonck DE, Faes C. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax. 2011;66(9):748–54.

  30. 30.

    Bhinder S, Chen H, Sato M, Copes R, Evans G, Chow CW, Singer L. Air pollution and the development of posttransplant chronic lung allograft dysfunction. Am J Transplan. 2014;14(12):2749–57.

  31. 31.

    Verleden S, Scheers H, Nawrot T, Vos R, Fierens F, Geenens R, Yserbyt J, Wauters S, Verbeken E, Nemery B. Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution. Am J Transplant. 2012;12(7):1831–8.

  32. 32.

    van Voorhis M, Knopp S, Julliard W, Fechner JH, Zhang X, Schauer JJ, Mezrich JD. Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor. PloS one. 2013;8(12):e82545.

Download references


This work was supported by the Seoul National University Research Grant in 2018, the Korean Society of Nephrology Grant in 2018 (BAXTER), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1A6A3A01095329) and the Global Research Lab through the NRF, funded by the Ministry of Science and ICT (Information and Communication Technologies) in South Korea (grant number K2100400000110A0500–00710; H Kim).

Author information




Research idea and study design: Y.S.K., E.K., J.P.L., and H.K.; data acquisition: Y.C.K. and E.K. J.J., J.Y.P., H.L., and D.K.K.; data analysis/interpretation: Y.C.K., E.K., Y.S.K., C.S.L., and H.K.; drafted and revised the paper: Y.C.K., E.K., and J.P.L. All authors have approved the final version of the manuscript.

Corresponding authors

Correspondence to Jung Pyo Lee or Ho Kim.

Ethics declarations

Ethics approval and consent to participate

The present study was conducted with the approval of the Research Ethics Committee of the Seoul National University Hospital. All procedures were performed in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The requirement to obtain informed consent was waived by the IRB due to the retrospective nature of this study.

Consent for publication

Not applicable.

Competing interests

Drs. Yong Chul Kim, Ejin Kim, Jiyun Jung, Jae Yoon Park, Hajeong Lee, Dong Ki Kim, Yon Su Kim, Chun Soo Lim, Jung Pyo Lee, and Ho Kim declare that they have no relevant financial and non-financial conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

Location map of the study participants. Table S1. Risk of BPR in PM 10 concentration by exposure durations from events day. Table S2. Risk of DCGF in PM 10 concentration by exposure durations from events day. Table S3.. Risk of all-cause mortality in PM 10 concentration by exposure durations from events day. Table S4. Association between average annual PM10 and SO2, CO, NO2 and O3 exposure in outcomes after kidney transplant.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kim, Y.C., Kim, E., Jung, J. et al. Clinical outcomes associated with long-term exposure to airborne particulate pollution in kidney transplant recipients. Environ Health 20, 61 (2021).

Download citation


  • Long-term PM10 exposure
  • Kidney transplant recipients
  • Outcomes